Dr. Jianjun ZOU, General Manager and CEO of Junshi Biosciences, said, “As of now, toripalimab has been approved for marketing in over 30 countries and regions across three continents worldwide. With ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

That brings us to Summit Therapeutics (NASDAQ: SMMT), a drugmaker whose shares have skyrocketed by almost 700% since the year ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

It is Transgene's second most advanced neoantigen immunotherapy programme after TG4050 for head and neck cancer, which is in ...